RhumbLine Advisers’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.21M | Buy |
128,732
+7,922
| +7% | +$74.2K | ﹤0.01% | 2155 |
|
2025
Q1 | $1.48M | Buy |
120,810
+7,361
| +6% | +$90.4K | ﹤0.01% | 1964 |
|
2024
Q4 | $1.5M | Sell |
113,449
-1,010
| -0.9% | -$13.4K | ﹤0.01% | 2032 |
|
2024
Q3 | $2.2M | Sell |
114,459
-4,826
| -4% | -$92.9K | ﹤0.01% | 1853 |
|
2024
Q2 | $2.45M | Buy |
119,285
+10,291
| +9% | +$211K | ﹤0.01% | 1781 |
|
2024
Q1 | $2.59M | Buy |
108,994
+13,677
| +14% | +$326K | ﹤0.01% | 1777 |
|
2023
Q4 | $2.06M | Sell |
95,317
-3,652
| -4% | -$78.9K | ﹤0.01% | 1889 |
|
2023
Q3 | $1.44M | Buy |
98,969
+671
| +0.7% | +$9.74K | ﹤0.01% | 2019 |
|
2023
Q2 | $2.06M | Buy |
98,298
+7,444
| +8% | +$156K | ﹤0.01% | 1892 |
|
2023
Q1 | $1.92M | Buy |
90,854
+10,286
| +13% | +$217K | ﹤0.01% | 1826 |
|
2022
Q4 | $2.05M | Buy |
80,568
+1,780
| +2% | +$45.3K | ﹤0.01% | 1772 |
|
2022
Q3 | $1.89M | Buy |
78,788
+7,522
| +11% | +$181K | ﹤0.01% | 1798 |
|
2022
Q2 | $1.37M | Buy |
71,266
+13,027
| +22% | +$251K | ﹤0.01% | 1968 |
|
2022
Q1 | $1.01M | Buy |
58,239
+1,516
| +3% | +$26.3K | ﹤0.01% | 2126 |
|
2021
Q4 | $1.24M | Sell |
56,723
-776
| -1% | -$17K | ﹤0.01% | 2120 |
|
2021
Q3 | $1.1M | Buy |
57,499
+2,100
| +4% | +$40.1K | ﹤0.01% | 2182 |
|
2021
Q2 | $951K | Buy |
55,399
+23,631
| +74% | +$406K | ﹤0.01% | 2265 |
|
2021
Q1 | $710K | Sell |
31,768
-925
| -3% | -$20.7K | ﹤0.01% | 2339 |
|
2020
Q4 | $727K | Buy |
32,693
+1,967
| +6% | +$43.7K | ﹤0.01% | 2278 |
|
2020
Q3 | $454K | Sell |
30,726
-3,018
| -9% | -$44.6K | ﹤0.01% | 2328 |
|
2020
Q2 | $500K | Buy |
33,744
+10,270
| +44% | +$152K | ﹤0.01% | 2345 |
|
2020
Q1 | $258K | Buy |
23,474
+420
| +2% | +$4.62K | ﹤0.01% | 2468 |
|
2019
Q4 | $202K | Buy |
23,054
+203
| +0.9% | +$1.78K | ﹤0.01% | 2745 |
|
2019
Q3 | $171K | Sell |
22,851
-140
| -0.6% | -$1.05K | ﹤0.01% | 2784 |
|
2019
Q2 | $214K | Buy |
22,991
+3,726
| +19% | +$34.7K | ﹤0.01% | 2769 |
|
2019
Q1 | $101K | Sell |
19,265
-145
| -0.7% | -$760 | ﹤0.01% | 2856 |
|
2018
Q4 | $86K | Buy |
19,410
+5,350
| +38% | +$23.7K | ﹤0.01% | 2900 |
|
2018
Q3 | $114K | Sell |
14,060
-625
| -4% | -$5.07K | ﹤0.01% | 2849 |
|
2018
Q2 | $103K | Buy |
+14,685
| New | +$103K | ﹤0.01% | 2869 |
|